By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cronus Technologies has inked a distribution deal with PamGene International covering the UK and Ireland.

The deal, the terms of which were not disclosed, calls for UK-based Cronus to sell and market the PamStation 12 and PamChip microarrays. The PamStation 12 is a fully automated instrument for processing PamChip microarrays that provides real-time measurement of peptide phosphorylation by protein kinases in any sample type.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.